sb 203580 has been researched along with decitabine in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (decitabine) | Trials (decitabine) | Recent Studies (post-2010) (decitabine) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 3,804 | 205 | 2,177 |
| Protein | Taxonomy | sb 203580 (IC50) | decitabine (IC50) |
|---|---|---|---|
| DNA (cytosine-5)-methyltransferase 1 | Homo sapiens (human) | 0.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basma, H; Cheng, PW; Christman, J; Klinkebiel, D; Radhakrishnan, P | 1 |
1 other study(ies) available for sb 203580 and decitabine
| Article | Year |
|---|---|
Cell type-specific activation of the cytomegalovirus promoter by dimethylsulfoxide and 5-aza-2'-deoxycytidine.
Topics: Acetylation; Animals; Azacitidine; beta-Galactosidase; Cattle; Cell Line; Coumarins; Cricetinae; Cytomegalovirus; Decitabine; Dimethyl Sulfoxide; DNA Methylation; Dose-Response Relationship, Drug; Gene Expression Regulation, Viral; Histones; I-kappa B Kinase; Imidazoles; N-Acetylglucosaminyltransferases; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Protein Biosynthesis; Pyridines; Time Factors; Transcription, Genetic; Up-Regulation | 2008 |